Biomedical, Clinical & Life Sciences

Submit ticket request  // Limit:1  // Tickets Available: 1

No pre-proposals were received in the internal competition.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. 

To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: 

• Courses for Skills Development

• Research Experiences

• Mentoring Activities

 Limit: 1 // PIs: B. Eckert & D. Axon (College of Pharmacy)

In general, multiple applications associated with the same DUNS number and/or Employee Identification Number (EIN) are not allowable. However, HRSA recognizes a growing trend towards greater consolidation within the rural health care industry and the possibility that multiple health care organizations may share the same EIN as its parent organization. 

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2024 Rural Health Network Development Planning Program. The purpose of this program is to promote the planning and development of integrated health care networks to address the following legislative aims: (i) achieve efficiencies; (ii) expand access to, coordinate, and improve the quality of basic health care services and associated health outcomes; and (iii) strengthen the rural health care system as a whole. 

No Applicants // Limit: 1 // Tickets Available: 1 

The foundation will consider more than one application per institution per year, but only one application per laboratory/mentor per year.

The Lalor Foundation postdoctoral fellowship program supports promising new researchers in establishing scientific and teaching careers. The program’s mission is to support these researchers early in their work so that they can become independently funded in the field of mammalian reproductive biology as related to the regulation of fertility. The Lalor Foundation will award fellows $55,000 per year to cover a fellowship stipend, fringes, and institutional overhead. Other expenses are not allowed. Institutional overhead may not exceed 10 percent of the total fellowship award. Renewal for one additional year is possible; please refer to specific renewal information under Application Instructions. 

 Limit: 4 //

M. Verhougstraete (Community, Environment & Policy)
J. Schroeder (Molecular and Cellular Biology)
H. Cai (Neuroscience)
J. Bibb (Translational Neurosciences)
 

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support. 

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase.  The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.
 

Application Guidance:

• Grant budgets cannot exceed $600-750K 
• The Foundation primarily supports basic science, ideally with potential translational applications.
• Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
• Covid-19-related research projects (aims or sub-aims) will not be considered for support.
• Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
• Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
• As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
• Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
• Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
• Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
• Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.

No applicants  // Limit: 1 // Tickets Available: 1 

The Health Resources and Services Administration (HRSA) is accepting applications for fiscal year (FY) 2019 Healthy Start Initiative: Eliminating Disparities in Perinatal Health. The purpose of this Healthy Start (HS)program is to improve health outcomes before, during, and after pregnancy, and reduce racial/ethnic differences in rates of infant death and adverse perinatal outcomes. 

HS has two focus areas: 1) providing direct and enabling services (for example, screening and referrals, case management and care coordination, health and parenting education, and linkage to clinical care) to enrolled HS participants; and 2) convening Community Consortia (formerly known as Community Action Networks or “CANs”) comprised of diverse, multi-sector partners to advise and inform HS activities as well as to develop and implement plans to improve perinatal outcomes within the selected project area. HS continues to have an increased emphasis on addressing social determinants of health, such as access to adequate food, housing, and transportation, to improve disparities in maternal and infant health outcomes. Based on stakeholder feedback, this FY 2024 HS competition also provides recipients with increased flexibility to tailor interventions to the unique needs of their community and/or target population.

The goals of HS are to:

1) Continue reducing infant mortality rates in the United States, and

2) Decrease disparities in infant mortality and poor perinatal health outcomes in areas where those rates are high.

No Applicants  // Limit: 1 // Tickets Available: 1 

The APECx program aims to create a toolkit to enable accurate chimeric and broadly efficacious vaccine Ag discovery through predictive modeling, high-throughput functional experimentation, and protein engineering. To fundamentally transform the vaccine research and development (R&D) sector, APECx will develop an innovative viral Ag prediction pipeline for broad efficacy by combining expedited experimental protein structure and function determination with high-throughput Ag screening. This will be enhanced with structural and functional prediction and protein modeling algorithms. Product developers will contribute to modeling tool evaluation from the start of the program to ensure discoveries satisfy the translational requirements. The combined effort of all the teams will create a toolkit that will enable the U.S. to achieve genus-level vaccine goals and prevent multiple viral diseases, including those responsible for cancer, acute disease, and chronic illness across the country and the world. 

Limit: 1 // PI: S. Radovick (Clinical and Translational Science Institute)

The CTSA Program hubs will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination and promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally.

Both a UM1 hub application and the required K12 Clinical Scientist Institutional Career Development Program Award (NOT-TR-21-030) must be submitted.

 Limit: 2 // J.  Green (Environmental Science), L. Ikner (Environmental Science)

*Deadline note: Due to the competitive nature of this funding program, this selection process is running with an anticipated deadline.
We will inform all applicants of relevant updates in the guidelines, submission deadlines, and eligibility as soon as more information becomes available.

The Packard Fellowships for Science and Engineering Program invests in future leaders who can take risks, explore new frontiers in their fields of study, and follow uncharted paths that may lead to groundbreaking discoveries.

The Foundation established the Packard Fellowships for Science and Engineering to allow the nation's most promising early career professors to pursue their science and engineering research with few funding restrictions and limited paperwork requirements.

Competitive Proposals Will explain clearly in the nomination letter(s) why the investigator is creative, innovative and promising. The proposed research program has breakthrough potential and reflects that promise and a sense of adventure and creativity. Proposals should put the work and its significance in context of the larger field. And differentiates projects should be accessible to a group of very successful scientists from a diverse set of fields (i.e. stay away from field-specific jargon). Projects must have high impact referees that can emphasize the significance and impact of the “big idea” and how the fellowship will significantly impact the nominee’s career.

Eligibility:

• Candidates must be faculty members who are eligible to serve as principal investigators engaged in research in the natural and physical sciences or engineering and must be within the first three years of their faculty careers.
• Disciplines that will be considered include biology, chemistry, bio-medical engineering, physics, chemistry, mathematics, biology, astronomy, computer science, earth science, ocean science, and all branches of engineering. Candidates engaged in research in the social sciences will not be considered.
• Candidates must be faculty members in the first three years of their faculty careers, that is, whose initial appointment began no earlier than May 31, 2021, and no later than May 31, 2024.

No Applicants // Limit: 1 // Tickets Available: 1 

The purpose of this research NOFO is to follow a cohort of interstitial cystitis (IC) patients over time, define the demographic and clinical patterns of IC, and document its impact on the health of affected people. In addition, the focus of this NOFO will include translating the scientific knowledge on IC extracted from previously funded and other studies so it can be used to support public health action, including patient strategies for improving quality of life, provider awareness and education, and medical and self-management of IC; strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC.

The estimated total funding (direct and indirect) for the first budget period (9/30/2024 to 9/29/2025) is $830,000. The estimated total funding (direct and indirect) for the entire performance period (9/30/2024 to 9/29/2029) is $4,150,000. The estimated award ceiling is $900,000 for the first 12-month budget period (9/30/2024 to 9/29/2025).